QuantoBio
Daxing
About QuantoBio
QuantoBio creates, manufactures, and conducts scientific research. Their products are clinical diagnostic biological reagents. They developed technological foundations for molecular immunology, luminous biochemistry, cellular immunity, and protein immunity. They offer a variety of goods and services, including functional research and diagnostic reagents based on microRNA expression profiling, as well as microRNA expression profiling and diagnostic reagents. Their clinical products are used for tumour early detection and clinical immune function.These include items from the chemiluminescence series, products for flow cytometry, molecular diagnostics, and protein immunology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $14.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2017)
- Ticker: neeq:835093
- Website: quantobio.com
- Phone: +86-10-59773899
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/quantobio-2240300 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.